|
US2021113094A1
|
|
Method and examination apparatus for medical examination of an animal
|
|
WO2021074292A1
|
|
Examination apparatus for medical examination of an animal
|
|
US2021063291A1
|
|
Filter instrument, kit and method for pretreating a sample
|
|
WO2020239569A1
|
|
Inhalers as well as protective device and breath indicator
|
|
US2020354410A1
|
|
Modified s1 subunit of the coronavirus spike protein
|
|
WO2020229257A1
|
|
Attenuated ibv with extended cell culture and tissue tropism
|
|
WO2020229249A1
|
|
Modified s2 subunit of the coronavirus spike protein
|
|
WO2021006942A1
|
|
Telmisartan for the treatment of hypertension in dogs
|
|
WO2021006941A1
|
|
Telmisartan for the treatment of chronic kidney disease in dogs
|
|
US2020306360A1
|
|
Immunogenic compositions and vaccines comprising african swine fever virus peptides and proteins and uses thereof
|
|
WO2020148363A1
|
|
Oral composition comprising saccharides for the diagnosis of insulin dysregulation in equines and methods of use thereof
|
|
WO2020093984A1
|
|
Immunogenic composition against avian influenza virus h5 subtype
|
|
WO2020089166A1
|
|
H52 ibv vaccine with heterologous spike protein
|
|
WO2020089164A1
|
|
4/91 ibv vaccine with heterologous spike protein
|
|
US2020101457A1
|
|
Peristaltic pump and analyzer for testing a sample
|
|
CA3109892A1
|
|
Fluid sensor, system for testing a sample and process
|
|
CA3109409A1
|
|
Analyzer and method for testing a sample
|
|
WO2020070012A1
|
|
Analyzer for testing a sample
|
|
WO2020058327A1
|
|
Modified pedv spike protein
|
|
WO2020058341A1
|
|
Intranasal vector vaccine against porcine epidemic diarrhea
|
